Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-30), Shenzhen Chipscreen Biosciences Co's Beta is 1.7050.
Shenzhen Chipscreen Biosciences Co (SHSE:688321) Beta Explanation
Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.
Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
Shenzhen Chipscreen Biosciences Co Beta Related Terms
Shenzhen Chipscreen Biosciences Co Beta Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Chipscreen Biosciences Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen Chipscreen Biosciences Co Beta vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shenzhen Chipscreen Biosciences Co's Beta distribution charts can be found below:
* The bar in red indicates where Shenzhen Chipscreen Biosciences Co's Beta falls into.
Shenzhen Chipscreen Biosciences Co Beta Calculation
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.
Shenzhen Chipscreen Biosciences Co (SHSE:688321) has a Beta of 1.7050 as of Jun. 30, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Shenzhen Chipscreen Biosciences Co and its competitors.
Is Shenzhen Chipscreen Biosciences Co's Beta too high?
Shenzhen Chipscreen Biosciences Co's current Beta is 1.7050. Overall, Shenzhen Chipscreen Biosciences Co has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Chipscreen Biosciences Co's Beta compare to ZTS and UTHR?
Shenzhen Chipscreen Biosciences Co's Beta of 1.7050 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Shenzhen Chipscreen Biosciences Co and its competitors. Shenzhen Chipscreen Biosciences Co's current Beta is 1.7050. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Chipscreen Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen Chipscreen Biosciences Co (SHSE:688321) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥37.53, compared to a current price of ¥26.33 — trading 29.8% below its estimated fair value. The current Beta is 1.7050. Shenzhen Chipscreen Biosciences Co's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Shenzhen Chipscreen Biosciences Co (SHSE:688321), the current Beta is 1.7050 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shenzhen Chipscreen Biosciences Co (SHSE:688321) Overvalued in 2026?
Based on GuruFocus' analysis, Shenzhen Chipscreen Biosciences Co stock appears to be undervalued.
The current stock price of ¥26.33 is trading 29.8% below its estimated GF Value™ of ¥37.53.
GuruFocus considers Shenzhen Chipscreen Biosciences Co to be Significantly Undervalued.
Key valuation signals for SHSE:688321:
Beta: 1.7050
GF Value™: ¥37.53 vs. price of ¥26.33 (29.8% below fair value)
No single metric tells the full story. See the SHSE:688321 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shenzhen Chipscreen Biosciences Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688321 has been successfully added to your 
